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Mitochondrial permeability transition′-bisindole isomer, is a component of Indigo naturalis and is an active ingredient
used in traditional Chinese medicine for the treatment of chronic diseases. The family of indirubin
derivatives, such as indirubin-3′-oxime, has been suggested for various therapeutic indications. However,
potential toxic interactions such as indirubin effects on mitochondrial bioenergetics are still unknown. This
study evaluated the action of indirubin-3′-oxime on the function of isolated rat liver mitochondria
contributing to a better understanding of the biochemical mechanisms underlying the multiple effects of
indirubin. Indirubin-3′-oxime incubated with isolated rat liver mitochondria, at concentrations above 10μM,
significantly depresses the phosphorylation efficiency of mitochondria as inferred from the decrease in the
respiratory control and ADP/O ratios, the perturbations in mitochondrial membrane potential and in the
phosphorylative cycle induced by ADP. Furthermore, indirubin-3′-oxime at up to 25μM stimulates the rate of
state 4 respiration and inhibits state 3 respiration. The increased lag phase of repolarization was associated
with a direct inhibition of the mitochondrial ATPase. Indirubin-3′-oxime significantly inhibited the activity of
complex II and IV thus explaining the decreased FCCP-stimulated mitochondrial respiration. Mitochondria
pre-incubated with indirubin-3′-oxime exhibits decreased susceptibility to calcium-induced mitochondrial
permeability transition. This work shows for the first time multiple effects of indirubin-3′-oxime on
mitochondrial bioenergetics thus indicating a potential mechanism for indirubin-3′-oxime effects on cell
function.
© 2008 Elsevier Inc. All rights reserved.IntroductionIndirubin, a red colored 3,2′-bisindole isomer, is a component of
Indigo naturalis and is an active ingredient used in traditional Chinese
medicine for the treatment of chronic diseases such as leukemias
(Eisenbrandet al., 2004). Several papers describing theproperties of the
indirubin family as cyclin-dependent kinases (CDKs) (Hoessel et al.,
1999; Leclerc et al., 2001) and glycogen synthase kinase-3β (GSK-3β)
(Leclerc et al., 2001; Meijer et al., 2003) inhibitors unravelled the
potential therapeutic indication of these compounds. Indirubin and
derivatives may have important implications for the development of
therapies for many diseases such as ischemia–reperfusion, Alzheimer's
disease, cancer and type 2 diabetes (Barillas et al., 2007; Meijer et al.,
2003; Jope et al., 2007), aswell as in stemcell therapy (Sato et al., 2004).
Numerous indirubin analogs have been synthesized to optimize
this promising drug scaffold. Indirubin-3′-oxime is an analogue of
indirubin commercially available. Addition of a 3-oxime substitutionl rights reserved.led to an overall increase in kinase inhibitory effects (Zhang et al.,
2006) and increased solubility (Meijer et al., 2003). However, drugs for
various therapeutic indications frequently have unexpected effects as
a result from unknown interactions between the intended drug and
biochemical pathways. Such unexpected activities may lead to adverse
effects and toxicity, thus disabling the potential therapeutic action. In
the last years, several mitochondrial off targets of drug action have
been shown as responsible for adverse effects. Such mitochondrial
toxicity leads to metabolic failure since mitochondria constitute the
principal energy-producing organelles of the cell through oxidative
phosphorylation. Therefore, alterations of mitochondrial bioenergetic
features by mitochondrial toxicants perturb energetic charge and
balance of cell and may cause drastic consequences on cellular
function.
Previous studies suggest an activity of indirubin and its derivates on
themitochondria (Lee et al., 2005 andMacDonald et al., 2006), however
the effectof indirubin inmitochondrial bioenergetics remainsunknown.
So, this studyexamines the effects of indirubin-3′-oxime in bioenergetic
functions of isolated rat liver mitochondria contributing to a better
comprehension of biochemical mechanisms underlying the effects of
indirubin. By using a cell-free model such as isolated mitochondria as
the experimental model it is possibly to clearly identify if indirubin-3′-
Fig. 1. (A) Mitochondrial transmembrane potential (ΔΨ); (B) Lag phase in succinate-energized liver mitochondria isolated, upon incubation with indirubin-3′-oxime. ΔΨ was
measured with a TPP+-selective electrode. Reactions were carried out in 1 ml of reaction medium, supplemented with 2 μM rotenone and 1 mg of freshly isolated mitochondria, as
described in Materials and methods. Energization was achieved with 5 mM succinate and phosphorylation induced by 200 nmol ADP. The traces represent typical direct recordings
and data are means±S.E.M of experiments performed with four different mitochondrial preparations. ⁎ indicates statistically significant difference versus control (Pb0.05).
Fig. 2. (A) State 3 respiration and FCCP-stimulated oxygen consumption (V FCCP); (B) State 4 respiration and oligomycin-inhibited oxygen consumption; (C) Respiratory control ratio
(RCR); (D) ADP/O in liver mitochondria, upon incubation with indirubin-3′-oxime. Reactions were carried out in 1.4 ml of reaction medium, supplemented with 2 μM rotenone and
1 mg of freshly isolated mitochondria, as described in Materials and methods. Energization was achieved with 5 mM succinate and phosphorylation induced by 200 nmol ADP. Data
are means±S.E.M of three different mitochondria preparations. For panel A, ⁎ indicates statistically significant difference in state 3 respiration versus control (Pb0.05), # indicates
statistically significant difference in V FCCP versus control (Pb0.05). For panel B, ⁎ indicates statistically significant difference in state 4 respiration versus control (Pb0.05), # indicates
statistically significant difference in V Oligomycin versus control (Pb0.05). For panels C and D, ⁎ indicates statistically significant difference versus control (Pb0.05).
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phosphorylation or interference with the oxidation of reducing
substrates that deliver electrons to the respiratory chain.
Materials and methods
Chemicals. All compounds were purchased from Sigma Chemical Co.
(St. Louis, MO). All other reagents and chemicals used were the highest
grade of purity commercially available.
Incubations with indirubin-3′-oxime. Stock solutions of indirubin-3′-
oxime were prepared in DMSO. Mitochondria were incubated with
several concentrations of indirubin-3′-oxime at 25 °C for 3min. Similar
concentrations of DMSOwere added to control preparations in order to
exclude solvent effect. The final concentration of DMSO was less than
0.01%.
Preparation of liver mitochondria. Mitochondria were isolated from
the liver of male Wistar rats by conventional methods (Gazotti et al.,
1979) with slight modifications (Rolo et al., 2000). Protein content
was determined by the biuret method (Gornall et al., 1949) calibrated
with bovine serum albumin.
Mitochondrial respiration. Oxygen consumption of isolated mito-
chondria was polarographically determined with a Clark oxygen
electrode (Estabrook, 1967), as previously described (Rolo et al.,
2000). Mitochondria (1 mg) were suspended under constant stirring,
at 25 °C, in 1.4ml of standard respiratorymedium (130mM sucrose, 50
mMKCl, 5mMMgCl2, 5mMKH2PO4, 50 μMEDTA, and5mMHEPES (pH
7.4) and 2 μM rotenone). Indirubin-3′-oxime was added to the
respiratory medium with mitochondria and allowed to incubate for 3
min before the addition of succinate (5mM). State 3 respiration was
induced by adding 200 nmol ADP. The oxygen consumption was also
measured in the presence of oligomycin (0.5 μg/mg protein) and 1 μM
carbonylcyanide-p-trifluoromethoxyphenylhydrazon (FCCP).
Membrane potential (ΔΨ) measurements. ΔΨ was estimated using
an ion-selective electrode to measure the distribution of
tetraphenylphosphorium (TPP+) according to previously established
methods (Kamo et al., 1979 and Palmeira et al., 1994). Mitochondria
(1 mg) were suspended in 1ml of standard respiratory medium (as
in mitochondrial respiration) supplemented with 3 μM TPP+.
Indirubin-3′-oxime was added to the respiratory medium with
mitochondria and TPP+ and allowed to incubate for 3 min before theFig. 3. ATPase activity in liver mitochondria incubated with indirubin-3′-oxime. ATPase
activity was evaluated spectrophotometrically at 660 nm, in association with ATP
hydrolysis. Reactions were carried out in 2 ml of reaction medium, supplemented with
0.25 mg of freeze–thawed mitochondria, as described in Materials and methods. Data
are means±S.E.M of three different mitochondrial preparations. ⁎ indicates statistically
significant difference versus control (Pb0.05).addition of succinate (5 mM). A matrix volume of 1.1 μl/mg protein
was assumed.
Measurement of the mitochondrial permeability transition. Mito-
chondrial swelling was estimated by changes in light scattering, as
monitored spectrophotometrically at 540 nm (Palmeira and Wallace,
1997). The incubationmediumcontained 200mMsucrose,10mMTris–
Mops (pH7.4),1mMKH2PO4, and10 μMEGTA supplementedwith 2 μM
rotenone and 5 mM succinate. The reaction was stirred continuously
and the temperature maintained at 25 °C. The experiments were
started by the addition of 1 mg of mitochondria (final volume 2 ml).
Calcium was added after incubation for 3 min of indirubin-3′-oxime
with mitochondria.
ATPase activity. ATPase activity was determined spectrophoto-
metrically at 660 nm, in association with ATP hydrolysis. The reaction
was carried out at 37 °C, in 2 ml reaction medium (125 mM sucrose,
65 mM KCl, 2.5 mM MgCl2 and 0.5 mM HEPES, pH 7.4). After the
addition of freeze–thawedmitochondria (0.25mg), indirubin-3′-oxime
was added and allowed to incubate for 3 min before the initiation of
reaction with the addition of 2 mM Mg2+-ATP, in the presence or
absence of oligomycin (1 μg/mg protein). After 10min, the reactionwas
stopped by adding 1 ml of 40% trichloroacetic acid and the samples
centrifuged for 5 min at 3000 rpm. 2 ml of ammoniummolybdate plus
2ml dH2Owere then added to 1ml of supernatant. ATPase activity was
calculated as the difference in total absorbance and absorbance in the
presence of oligomycin.
Cytochrome c oxidase activity. Cytochrome c oxidase activity was
polarographically determined, as previously described (Brautigan et al.,
1978). The reaction was carried out at 25 °C in 1.4 ml of standard
respiratory medium (as in mitochondrial respiration) supplemented
with 2 μM rotenone, 10 μM oxidized cytochrome c and 0.3 mg Triton
X-100. After the addition of freeze–thawed mitochondria (0.5 mg),
indirubin-3′-oxime was added and allowed to incubate for 3 min
before the initiation of the reaction by adding 5 mM ascorbate plus
0.25 mM tetramethylphenylene-diamine (TMPD).
Succinate dehydrogenase activity. Succinate dehydrogenase activity
was polarographically determined as previously described (Singer,
1994). The reaction was carried out at 25 °C in 1.4 ml of standard
respiratory medium (as in mitochondrial respiration) supplemented
with 5mMsuccinate, 2 μMrotenone, 0.1 μg antimycin A,1mMKCNand
0.3mg Triton X-100. After the addition of freeze–thawedmitochondria
(0.5 mg), indirubin-3′-oxime was added and allowed to incubate for
3 min before the initiation of reaction with 1 mM phenazinemeta-
sulphate (PMS).
Measurement of mitochondrial calcium fluxes. The accumulation and
release of calcium by isolated rat liver mitochondria were determinate
using a calcium-sensitive fluorescent dye, Calcium Green-5 N (Rajdev
and Reynolds, 1993). The reactions were carried out at 25 °C, in 2 ml of
standard incubationmedium (200 mM sucrose, 10 mM Tris–MOPS (pH
7.4),1mMKH2PO4 and10 μMEGTA), supplementedwith 2 μMrotenone
and 0.5 μg/mg protein of oligomycin. Free calciumwas monitored with
100 nM calcium Green 5-N. Mitochondria (1 mg) were suspended in
twelve well plates. Energization was obtained with succinate (5 mM).
Fluorescence was recorded continuously using a Perkin-Elmer VICTOR
3, with excitation and emission wavelengths of 485 and 535,
respectively. Calcium fluxes are expressed as relative fluorescence
units (RFU). At the concentrations used, indirubin-3′-oxime did not
interfere with the experimental assay.
Statistical analysis. Results are presented as mean±SEM. Statistical
evaluation was performed using two-tails Student's t test. A P
value b 0.05 was considered statistically significant.
Fig. 4. (A) Cytochrome c oxidase activity; (B) Succinate dehydrogenase activity in liver
mitochondria incubated with indirubin-3′-oxime. Enzyme activity was polarographi-
cally determined with a Clark oxygen electrode. Mitochondria (0.5 mg) were suspended
under constant stirring, at 25 °C, in 1.4 ml of standard respiratory medium. The reaction
media was supplemented with 2 μM rotenone, 10 μM cytochrome c, 1 mM KCN, 0,3 mg
Triton X-100 and the reaction initiated by adding 0.25 mM ascorbate/TMPD. Data
expressed as means±SEM of three different mitochondrial preparations. For each panel,
⁎ indicates statistically significant difference versus control (Pb0.05).
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Effects of indirubin-3′-oxime in mitochondrial transmembrane potential
Taking into account the fundamental role of mitochondrial
transmembrane potential for the phenomenon of oxidative phosphor-
ylation, ΔΨ was evaluated in succinate-energized mitochondria (Fig.
1A). ΔΨ was decreased in mitochondria pre-incubated with indir-
ubin-3′-oxime 10 μM, 15 μM and 25 μM, being statistically significant
for the concentration of 25 μM.
ADP-induced depolarization and ΔΨ after repolarization (mito-
chondrial capacity to establish ΔΨ after ADP phosphorylation) was
also decreased in mitochondria pre-incubated with indirubin-3′-
oxime, but again it was only statistically significant for the
concentration of 25 μM. No differences were observed in mitochon-
drial transmembrane potential in mitochondria pre-incubated with
indirubin-3′-oxime 5 μM (data not shown).
The lag phase (time necessary for ADP phosphorylation) was
significantly enlargedwhenmitochondriawas incubated 10 μM,15 μM
and 25 μM with indirubin-3′-oxime (Fig. 1B).
Effects of indirubin-3′-oxime in mitochondrial respiration
Oxidative phosphorylation capacity was investigated by following
oxygen consumption upon succinate oxidation. Mitochondrial state 3
respiration (ADP-induced oxygen consumption) was significant
decreased in mitochondria pre-incubated with indirubin-3′-oxime 15
μM. Similarly, oxygen consumption stimulated by FCCP, a well known
respiratory chain uncoupler, was significant decreased inmitochondria
pre-incubated with indirubin-3′-oxime 10 μM and 15 μM (Fig. 2A).
The consumption of oxygen after ADP phosphorylation (state 4
respiration) was increased in mitochondria pre-incubated with
indirubin-3′-oxime 10 μM and 15 μM when compared with control
(Fig. 2B). Mitochondrial respiration in the presence of oligomycin, a
known inhibitor of the mitochondrial F1Fo-ATPsynthase, was
increased in mitochondria pre-incubated with indirubin-3′-oxime
10 μMand 15 μM, being statistically significant for the concentration of
15 μM (Fig. 2B).
The ratio between mitochondrial state 3 and state 4 respiration
(RCR), was significantly decreased in mitochondria pre-incubated
with indirubin-3′-oxime 10 μM and 15 μM (Fig. 2C). The ADP/O ratio,
an indicator of oxidative phosphorylation efficiency, showed a
tendency to decrease when mitochondria was incubated with
indirubin-3′-oxime. However, this decrease was statistically signifi-
cant only for 15 μM (Fig. 2D).
Effects of indirubin-3′-oxime in mitochondrial ATPase activity
The decreased performance of phosphorylation in mitochondria
pre-incubatedwith indirubin-3′-oxime, as reflected by an increased lag
phase and an increase in mitochondrial respiration in the presence of
oligomycin, suggested alterations in the F1Fo-ATPsynthase, a key
component of the phosphorylative system. ATPase activity was
decreased in mitochondria pre-incubated with indirubin-3′-oxime
with 10 μM,15 μMand25μM,being this decrease statistically significant
for 15 μM and 25 μM (Fig. 3).
Effects of indirubin-3′-oxime on succinate dehydrogenase and
cytochrome c oxidase activities
The decreased rate of oxygen consumption induced by FCCP in
mitochondria pre-incubated with indirubin-3′-oxime, suggested
alterations in the mitochondrial electron transport chain complexes.
In view of this, succinate dehydrogenase and cytochrome c oxidase
activities were evaluated. Mitochondria pre-incubated with indirubin-
3′-oxime 15 μM, 25 μMand50 μMexhibited decreased activities in bothof these enzymes, while mitochondria pre-incubated with indirubin-
3′-oxime 5 μM and 10 μM, didn't show significant differences in
activities of succinate dehydrogenase and cytochrome c oxidase,
comparatively to control (Figs. 4A and B).
Effects of indirubin-3′-oxime on the induction of the mitochondrial
permeability transition
Since mitochondria possess a finite capacity for accumulating
calcium before undergoing the MPT, calcium-induced mitochondrial
swelling was evaluated. Mitochondria pre-incubated with indirubin-
3′-oxime were less susceptible to undergo calcium-dependent mito-
chondrial swelling, comparatively to control (Fig. 5A). Mitochondria
pre-incubated with indirubin-3′-oxime and incubated with 100 μM
ADP revealed an increased threshold in calcium-induced swelling
comparatively to mitochondria incubated only with 100 μM ADP (Fig.
5B). Pre-treatment with 1 μM CyA completely prevented calcium-
dependent mitochondrial swelling, indicating that the decreased in
absorbance was the result of the calcium-induced MPT.
Effects of indirubin-3′-oxime on mitochondrial calcium flux
Since mitochondria pre-incubated with indirubin-3′-oxime
decreased the susceptibility to calcium-induced swelling, mitochon-
drial calcium fluxes were evaluated. Calcium uptake by mitochondria
was identical in both control and in mitochondria pre-incubated with
indirubin-3′-oxime. In control experiment, calcium that was taken by
Fig. 5. Calcium-induced mitochondrial permeability transition (MPT) in liver mitochondria incubated with indirubin-3′-oxime. Experiments were started by the addition of
mitochondria (1 mg) to 2 ml of reaction medium supplemented with 3 μM rotenone, 0.5 μg oligomycin and 5 mM succinate. MPT was induced with 20 μM CaCl2 where indicated by
the arrow. Cyclosporin A CyA (1 μM) was added to the reaction medium prior to calcium addition. For panel A, the traces are representative of experiments performed with
mitochondria pre-incubated with different concentrations of indirubin-3′-oxime concentrations. For panel B, the traces are representative of experiments performed with
mitochondria pre-incubated with 10 μM indirubin-3′-oxime and 100 nmol ADP.
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approximately 13 min. After this period of time, calcium was released
by MPT induction, as demonstrated by pre-treatment with 1 μM CyA,Fig. 6. Measurement of calcium fluxes in mitochondria incubated with indirubin-3′-oxime
described in Materials and methods) prior to calcium addition (10 μM). Energization was a
(RFU), were recorded for an additional 25 min. Cyclosporin A (CyA) 1 μMwas added to the rea
with mitochondria pre-incubated with different indirubin-3′-oxime concentrations.which completely prevented calcium release (Fig. 6). Pre-incubation
with indirubin-3′-oxime prevented the release of calcium by MPT
induction (Fig. 6).. Mitochondria (1 mg) were incubated in 2 ml of the standard incubation medium (as
chieved with succinate 5 mM. Calcium fluxes, expressed as relative fluorescence units
ction prior to calcium addition. The traces are representative of experiments performed
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The study of drug-induced mitochondrial toxicity may elucidate
distinct mechanisms bywhich drugs interfere with energy production
by the cell. The indirubin family of compounds has been associated
with putative therapeutic potential as an anti-cancer agent and in the
development of therapies for diabetes and Alzheimer's disease
(Hoessel et al., 1999; Leclerc et al., 2001; Shi and Shen, 2008).
Mitochondria play a key role in energy production, calcium home-
ostasis, generation of free radicals and apoptosis (Bernardi and Rasola,
2007; Orrenius, 2007). ATP synthesis by the mitochondrial oxidative
phosphorylation system is required to maintain cell viability since
almost all intracellular ATP is generated in the mitochondria and
about one-third of the cellular adenine nucleotides are located in
these organelles. Thus, disturbance of mitochondrial function has a
variety of functional consequences and is found in most human
diseases, including neurodegenerative diseases, stroke, cardiovascular
disorders, ischemia/reperfusion, and cancer (Wang et al., 2005; Hunt
et al., 2006; Halestrap et al., 2007; Kim et al., 2008). In this context,
damage to mitochondria can be a limiting factor in clinical settings,
disabling a potential therapeutic action of promising drugs. The aim of
this study was to evaluate if indirubin-3′-oxime is a mitochondrial
toxicant by interfering with the bioenergetic features of the
mitochondria.
Our results demonstrate that, in isolated rat liver mitochondria,
indirubin-3′-oxime impairs the oxidative phosphorylation capacity as
shown by decreased respiratory control ratio and ADP/O. Moreover,
indirubin-3′-oxime depresses both mitochondrial ΔΨ and state 3
respiration but induces stimulation of state 4 respiration. The
observed effects show that concentrations of indirubin-3′-oxime
higher than 10 μM affect mitochondrial function in a similar way. The
decrease in both state 3 respiratory rates and FCCP-induced oxygen
consumption indicated a loss of oxidative capacity in mitochondria
incubated with indirubin-3′-oxime. The decrease in oxygen con-
sumption reflects an inhibition of the maximal velocity of electron
flow from reduced substrates to oxygen in mitochondria incubated
with indirubin-3′-oxime, indicating a behavior of classical inhibitors
of the electron transport chain. As shown by the decrease in the
activities of the complexes of the electron transport chain, succinate
dehydrogenase and cytochrome c oxidase, indirubin-3′-oxime inhi-
bits both substrate oxidation and oxygen consumption, directly
affecting the activity of individual complexes of the electron
transport chain, thereby decreasing the electrical potential across
the inner mitochondrial membrane. Additionally, indirubin-3′-
oxime-induced increase in state 4 respiration, which paralleled the
partial collapse of the ΔΨ, probably reflects an uncoupling effect of
this drug on the oxidative phosphorylation system, resulting in an
increase in the permeability of the mitochondrial inner membrane to
protons (proton leak).
The increase in the lag phase and the decrease in the ADP/O ratio in
mitochondria incubated with indirubin-3′-oxime indicated an uncou-
pling between the oxidation of reduced substrates by the electron
transport chain and the phosphorylation of ADP to ATP by the
ATPsynthase. This decrease in the phosphorylative efficiency was
associated with an inhibitory action of indirubin directly on the
ATPsynthase. One interesting finding regarding the effects of
indirubin-3′-oxime on isolated mitochondria was that although the
impairment of oxidative phosphorylation, this compound had a
partial preventive role on calcium-induced MPT. MPT induction
disrupts the permeability barrier of the inner membrane, thus
dissipating the membrane potential and pH gradient that together
drive ATP synthesis through oxidative phosphorylation (Lemasters,
2007). The MPT is induced under conditions of high matrix calcium,
especially when this is accompanied by oxidative stress, high
phosphate and low adenine nucleotide concentrations (Lemasters,
2007). Since indirubin-3′-oxime decreases the ΔΨ and the mitochon-drial uptake of calcium is dependent on ΔΨ, indirubin-3′-oxime
partial protective action on calcium-induced MPT could be the result
of the prevention of excessive mitochondrial calcium accumulation.
However, mitochondrial calcium uptake was not affected by incuba-
tion of mitochondria with indirubin-3′-oxime. The observation that
the combination ADP plus indirubin-3′-oxime have a stronger
protective effect on calcium-induced MPT, may suggest that indir-
ubin-3′-oxime also interacts with components of the MPT thereby
affecting its induction.
In conclusion, our results demonstrate that indirubin-3′-oxime has
direct effects on mitochondrial function by disturbing the oxidative
phosphorylative efficiency that may lead to mitochondrial failure in
exposed cells. Work conducted by MacDonald and coworkers has
shown that in cells in culture exposed to indirubin for 1 h, there is a
90% decrease in ΔΨ, as well as inhibition of cell proliferation
(MacDonald et al., 2006). While our manuscript was in preparation,
Shi and Shen have shown that indirubin-3′-monoxime (in the range of
concentrations that affectmitochondrial bioenergetics) induces type II
cell apoptosis in HeLa cells with the critical involvement of the pro-
apoptotic proteins such as Bid and Bax at the level of mitochondria
(Shi and Shen, 2008). This work has drawn attention to an
unrecognized action of indirubin-3′-oxime on mitochondria, suggest-
ing a direct effect of the compound on mitochondrial function.
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